R&D Changing Faces – Pharma and Biotech Hires for July 2025 Perhaps it’s just the summer slowdown, but it’s been a light month for executive hires in the pharma and biotech world.
R&D Changing Faces - Pharma and Biotech Hires - March 2025 Once again, March saw a variety of biotech leadership hires on both the business and science sides of the industry.
R&D Changing Faces: Pharma and biotech November-December 2024 Welcome to the last edition of Changing Faces for 2024.
R&D Changing Faces: Pharma and biotech hires for August 2024 Welcome to the August edition of Changing Faces for the pharma and biotech sectors.
R&D Changing Faces – Pharma and biotech May and June 2024 Welcome back to another edition of Changing Faces.
R&D Changing Faces: Pharma and biotech hires from March 2024 Once again in March, the pharmaceutical world saw a series of notable hires. From biotech to pharma, companies are strengthening their teams with experienced professionals.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
